Skip to main content
Erschienen in: European Radiology 5/2016

30.08.2015 | Neuro

Evaluation of low-grade glioma structural changes after chemotherapy using DTI-based histogram analysis and functional diffusion maps

verfasst von: Antonella Castellano, Marina Donativi, Roberta Rudà, Giorgio De Nunzio, Marco Riva, Antonella Iadanza, Luca Bertero, Matteo Rucco, Lorenzo Bello, Riccardo Soffietti, Andrea Falini

Erschienen in: European Radiology | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To explore the role of diffusion tensor imaging (DTI)-based histogram analysis and functional diffusion maps (fDMs) in evaluating structural changes of low-grade gliomas (LGGs) receiving temozolomide (TMZ) chemotherapy.

Methods

Twenty-one LGG patients underwent 3T-MR examinations before and after three and six cycles of dose-dense TMZ, including 3D-fluid-attenuated inversion recovery (FLAIR) sequences and DTI (b = 1000 s/mm2, 32 directions). Mean diffusivity (MD), fractional anisotropy (FA), and tensor-decomposition DTI maps (p and q) were obtained. Histogram and fDM analyses were performed on co-registered baseline and post-chemotherapy maps. DTI changes were compared with modifications of tumour area and volume [according to Response Assessment in Neuro-Oncology (RANO) criteria], and seizure response.

Results

After three cycles of TMZ, 20/21 patients were stable according to RANO criteria, but DTI changes were observed in all patients (Wilcoxon test, P ≤ 0.03). After six cycles, DTI changes were more pronounced (P ≤ 0.005). Seventy-five percent of patients had early seizure response with significant improvement of DTI values, maintaining stability on FLAIR. Early changes of the 25th percentiles of p and MD predicted final volume change (R2 = 0.614 and 0.561, P < 0.0005, respectively). TMZ-related changes were located mainly at tumour borders on p and MD fDMs.

Conclusions

DTI-based histogram and fDM analyses are useful techniques to evaluate the early effects of TMZ chemotherapy in LGG patients.

Key Points

DTI helps to assess the efficacy of chemotherapy in low-grade gliomas.
Histogram analysis of DTI metrics quantifies structural changes in tumour tissue.
Functional diffusion maps (fDMs) spatially localize the changes of DTI metrics.
Changes in DTI histograms and fDMs precede changes in conventional MRI.
Early changes in DTI histograms and fDMs correlate with seizure response.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Castellano A, Bello L, Michelozzi C et al (2012) Role of diffusion tensor magnetic resonance tractography in predicting the extent of resection in glioma surgery. Neuro Oncol 14:192–202CrossRefPubMedPubMedCentral Castellano A, Bello L, Michelozzi C et al (2012) Role of diffusion tensor magnetic resonance tractography in predicting the extent of resection in glioma surgery. Neuro Oncol 14:192–202CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Talos IF, Zou KH, Ohno-Machado L et al (2006) Supratentorial low-grade glioma resectability: Statistical predictive analysis based on anatomic MR features and tumor characteristics. Radiology 239:506–513CrossRefPubMedPubMedCentral Talos IF, Zou KH, Ohno-Machado L et al (2006) Supratentorial low-grade glioma resectability: Statistical predictive analysis based on anatomic MR features and tumor characteristics. Radiology 239:506–513CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Smith JS, Chang EF, Lamborn KR et al (2008) Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26:1338–1345CrossRefPubMed Smith JS, Chang EF, Lamborn KR et al (2008) Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26:1338–1345CrossRefPubMed
5.
Zurück zum Zitat Soffietti R, Baumert BG, Bello L et al (2010) Guidelines on management of low-grade gliomas: Report of an EFNS-EANO task force. Eur J Neurol 17:1124–1133CrossRefPubMed Soffietti R, Baumert BG, Bello L et al (2010) Guidelines on management of low-grade gliomas: Report of an EFNS-EANO task force. Eur J Neurol 17:1124–1133CrossRefPubMed
6.
Zurück zum Zitat Keles GE, Lamborn KR, Berger MS (2001) Low-grade hemispheric gliomas in adults: A critical review of extent of resection as a factor influencing outcome. J Neurosurg 95:735–745CrossRefPubMed Keles GE, Lamborn KR, Berger MS (2001) Low-grade hemispheric gliomas in adults: A critical review of extent of resection as a factor influencing outcome. J Neurosurg 95:735–745CrossRefPubMed
7.
Zurück zum Zitat Brada M, Viviers L, Abson C et al (2003) Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol 14:1715–1721CrossRefPubMed Brada M, Viviers L, Abson C et al (2003) Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol 14:1715–1721CrossRefPubMed
8.
Zurück zum Zitat Pace A, Vidiri A, Galie E et al (2003) Temozolomide chemotherapy for progressive low-grade glioma: Clinical benefits and radiological response. Ann Oncol 14:1722–1726CrossRefPubMed Pace A, Vidiri A, Galie E et al (2003) Temozolomide chemotherapy for progressive low-grade glioma: Clinical benefits and radiological response. Ann Oncol 14:1722–1726CrossRefPubMed
9.
Zurück zum Zitat van den Bent MJ, Afra D, de Witte O et al (2005) Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: The EORTC 22845 randomised trial. Lancet 366:985–990CrossRefPubMed van den Bent MJ, Afra D, de Witte O et al (2005) Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: The EORTC 22845 randomised trial. Lancet 366:985–990CrossRefPubMed
10.
Zurück zum Zitat Duffau H, Taillandier L, Capelle L (2006) Radical surgery after chemotherapy: A new therapeutic strategy to envision in grade II glioma. J Neurooncol 80:171–176CrossRefPubMed Duffau H, Taillandier L, Capelle L (2006) Radical surgery after chemotherapy: A new therapeutic strategy to envision in grade II glioma. J Neurooncol 80:171–176CrossRefPubMed
11.
Zurück zum Zitat Blonski M, Taillandier L, Herbet G et al (2012) Combination of neoadjuvant chemotherapy followed by surgical resection as a new strategy for WHO grade II gliomas: A study of cognitive status and quality of life. J Neurooncol 106:353–366CrossRefPubMed Blonski M, Taillandier L, Herbet G et al (2012) Combination of neoadjuvant chemotherapy followed by surgical resection as a new strategy for WHO grade II gliomas: A study of cognitive status and quality of life. J Neurooncol 106:353–366CrossRefPubMed
12.
Zurück zum Zitat Blonski M, Pallud J, Goze C et al (2013) Neoadjuvant chemotherapy may optimize the extent of resection of world health organization grade II gliomas: A case series of 17 patients. J Neurooncol 113:267–275CrossRefPubMed Blonski M, Pallud J, Goze C et al (2013) Neoadjuvant chemotherapy may optimize the extent of resection of world health organization grade II gliomas: A case series of 17 patients. J Neurooncol 113:267–275CrossRefPubMed
13.
Zurück zum Zitat van den Bent MJ, Wefel JS, Schiff D et al (2011) Response assessment in neuro-oncology (a report of the RANO group): Assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol 12:583–593CrossRefPubMed van den Bent MJ, Wefel JS, Schiff D et al (2011) Response assessment in neuro-oncology (a report of the RANO group): Assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol 12:583–593CrossRefPubMed
14.
Zurück zum Zitat Galanis E, Buckner JC, Maurer MJ et al (2006) Validation of neuroradiologic response assessment in gliomas: Measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods. Neuro Oncol 8:156–165CrossRefPubMedPubMedCentral Galanis E, Buckner JC, Maurer MJ et al (2006) Validation of neuroradiologic response assessment in gliomas: Measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods. Neuro Oncol 8:156–165CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Sorensen AG, Patel S, Harmath C et al (2001) Comparison of diameter and perimeter methods for tumor volume calculation. J Clin Oncol 19:551–557PubMed Sorensen AG, Patel S, Harmath C et al (2001) Comparison of diameter and perimeter methods for tumor volume calculation. J Clin Oncol 19:551–557PubMed
16.
Zurück zum Zitat Dempsey MF, Condon BR, Hadley DM (2005) Measurement of tumor "size" in recurrent malignant glioma: 1D, 2D, or 3D? AJNR Am J Neuroradiol 26:770–776PubMed Dempsey MF, Condon BR, Hadley DM (2005) Measurement of tumor "size" in recurrent malignant glioma: 1D, 2D, or 3D? AJNR Am J Neuroradiol 26:770–776PubMed
17.
Zurück zum Zitat Rudà R, Bello L, Duffau H, Soffietti R (2012) Seizures in low-grade gliomas: Natural history, pathogenesis, and outcome after treatments. Neuro Oncol 14:iv55–64CrossRefPubMedPubMedCentral Rudà R, Bello L, Duffau H, Soffietti R (2012) Seizures in low-grade gliomas: Natural history, pathogenesis, and outcome after treatments. Neuro Oncol 14:iv55–64CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Price SJ, Pena A, Burnet NG et al (2004) Tissue signature characterisation of diffusion tensor abnormalities in cerebral gliomas. Eur Radiol 14:1909–1917CrossRefPubMed Price SJ, Pena A, Burnet NG et al (2004) Tissue signature characterisation of diffusion tensor abnormalities in cerebral gliomas. Eur Radiol 14:1909–1917CrossRefPubMed
19.
Zurück zum Zitat Goebell E, Paustenbach S, Vaeterlein O et al (2006) Low-grade and anaplastic gliomas: Differences in architecture evaluated with diffusion-tensor MR imaging. Radiology 239:217–222CrossRefPubMed Goebell E, Paustenbach S, Vaeterlein O et al (2006) Low-grade and anaplastic gliomas: Differences in architecture evaluated with diffusion-tensor MR imaging. Radiology 239:217–222CrossRefPubMed
20.
Zurück zum Zitat Stadlbauer A, Nimsky C, Buslei R et al (2007) Diffusion tensor imaging and optimized fiber tracking in glioma patients: Histopathologic evaluation of tumor-invaded white matter structures. Neuroimage 34:949–956CrossRefPubMed Stadlbauer A, Nimsky C, Buslei R et al (2007) Diffusion tensor imaging and optimized fiber tracking in glioma patients: Histopathologic evaluation of tumor-invaded white matter structures. Neuroimage 34:949–956CrossRefPubMed
21.
Zurück zum Zitat Sternberg EJ, Lipton ML, Burns J (2014) Utility of diffusion tensor imaging in evaluation of the peritumoral region in patients with primary and metastatic brain tumors. AJNR Am J Neuroradiol 35:439–444CrossRefPubMed Sternberg EJ, Lipton ML, Burns J (2014) Utility of diffusion tensor imaging in evaluation of the peritumoral region in patients with primary and metastatic brain tumors. AJNR Am J Neuroradiol 35:439–444CrossRefPubMed
22.
Zurück zum Zitat Pena A, Green HA, Carpenter TA, Price SJ, Pickard JD, Gillard JH (2006) Enhanced visualization and quantification of magnetic resonance diffusion tensor imaging using the p:Q tensor decomposition. Br J Radiol 79:101–109CrossRefPubMed Pena A, Green HA, Carpenter TA, Price SJ, Pickard JD, Gillard JH (2006) Enhanced visualization and quantification of magnetic resonance diffusion tensor imaging using the p:Q tensor decomposition. Br J Radiol 79:101–109CrossRefPubMed
23.
Zurück zum Zitat Price SJ, Jena R, Burnet NG, Carpenter TA, Pickard JD, Gillard JH (2007) Predicting patterns of glioma recurrence using diffusion tensor imaging. Eur Radiol 17:1675–1684CrossRefPubMed Price SJ, Jena R, Burnet NG, Carpenter TA, Pickard JD, Gillard JH (2007) Predicting patterns of glioma recurrence using diffusion tensor imaging. Eur Radiol 17:1675–1684CrossRefPubMed
24.
Zurück zum Zitat Price SJ, Jena R, Burnet NG et al (2006) Improved delineation of glioma margins and regions of infiltration with the use of diffusion tensor imaging: An image-guided biopsy study. AJNR Am J Neuroradiol 27:1969–1974PubMed Price SJ, Jena R, Burnet NG et al (2006) Improved delineation of glioma margins and regions of infiltration with the use of diffusion tensor imaging: An image-guided biopsy study. AJNR Am J Neuroradiol 27:1969–1974PubMed
25.
Zurück zum Zitat Nowosielski M, Recheis W, Goebel G et al (2011) ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma. Neuroradiology 53:291–302CrossRefPubMedPubMedCentral Nowosielski M, Recheis W, Goebel G et al (2011) ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma. Neuroradiology 53:291–302CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Pope WB, Qiao XJ, Kim HJ et al (2012) Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: A multi-center study. J Neurooncol 108:491–498CrossRefPubMedPubMedCentral Pope WB, Qiao XJ, Kim HJ et al (2012) Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: A multi-center study. J Neurooncol 108:491–498CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Hamstra DA, Chenevert TL, Moffat BA et al (2005) Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A 102:16759–16764CrossRefPubMedPubMedCentral Hamstra DA, Chenevert TL, Moffat BA et al (2005) Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A 102:16759–16764CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Ellingson BM, Malkin MG, Rand SD et al (2010) Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity. J Magn Reson Imaging 31:538–548CrossRefPubMedPubMedCentral Ellingson BM, Malkin MG, Rand SD et al (2010) Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity. J Magn Reson Imaging 31:538–548CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Belhawi SM, Hoefnagels FW, Baaijen JC et al (2011) Early postoperative MRI overestimates residual tumour after resection of gliomas with no or minimal enhancement. Eur Radiol 21:1526–1534CrossRefPubMedPubMedCentral Belhawi SM, Hoefnagels FW, Baaijen JC et al (2011) Early postoperative MRI overestimates residual tumour after resection of gliomas with no or minimal enhancement. Eur Radiol 21:1526–1534CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. european organization for research and treatment of cancer, national cancer institute of the united states, national cancer institute of canada. J Natl Cancer Inst 92:205–216CrossRefPubMed Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. european organization for research and treatment of cancer, national cancer institute of the united states, national cancer institute of canada. J Natl Cancer Inst 92:205–216CrossRefPubMed
31.
32.
Zurück zum Zitat Moffat BA, Chenevert TL, Lawrence TS et al (2005) Functional diffusion map: A noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A 102:5524–5529CrossRefPubMedPubMedCentral Moffat BA, Chenevert TL, Lawrence TS et al (2005) Functional diffusion map: A noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A 102:5524–5529CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat O'Connor JP, Jackson A, Asselin MC, Buckley DL, Parker GJ, Jayson GC (2008) Quantitative imaging biomarkers in the clinical development of targeted therapeutics: Current and future perspectives. Lancet Oncol 9:766–776CrossRefPubMed O'Connor JP, Jackson A, Asselin MC, Buckley DL, Parker GJ, Jayson GC (2008) Quantitative imaging biomarkers in the clinical development of targeted therapeutics: Current and future perspectives. Lancet Oncol 9:766–776CrossRefPubMed
34.
Zurück zum Zitat Sherman JH, Moldovan K, Yeoh HK et al (2011) Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomas. J Neurosurg 114:1617–1621CrossRefPubMed Sherman JH, Moldovan K, Yeoh HK et al (2011) Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomas. J Neurosurg 114:1617–1621CrossRefPubMed
35.
Zurück zum Zitat Jones TL, Byrnes TJ, Yang G, Howe FA, Bell BA, Barrick TR (2014) Brain tumor classification using the diffusion tensor image segmentation (D-SEG) technique. Neuro Oncol. doi:nou 159 [pii] Jones TL, Byrnes TJ, Yang G, Howe FA, Bell BA, Barrick TR (2014) Brain tumor classification using the diffusion tensor image segmentation (D-SEG) technique. Neuro Oncol. doi:nou 159 [pii]
36.
Zurück zum Zitat Khayal IS, McKnight TR, McGue C et al (2009) Apparent diffusion coefficient and fractional anisotropy of newly diagnosed grade II gliomas. NMR Biomed 22:449–455CrossRefPubMedPubMedCentral Khayal IS, McKnight TR, McGue C et al (2009) Apparent diffusion coefficient and fractional anisotropy of newly diagnosed grade II gliomas. NMR Biomed 22:449–455CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Hoefnagels FW, De Witt HP, Sanz-Arigita E et al (2014) Differentiation of edema and glioma infiltration: Proposal of a DTI-based probability map. J Neurooncol 120:187–198CrossRefPubMed Hoefnagels FW, De Witt HP, Sanz-Arigita E et al (2014) Differentiation of edema and glioma infiltration: Proposal of a DTI-based probability map. J Neurooncol 120:187–198CrossRefPubMed
38.
Zurück zum Zitat Pavlisa G, Rados M, Pavlisa G, Pavic L, Potocki K, Mayer D (2009) The differences of water diffusion between brain tissue infiltrated by tumor and peritumoral vasogenic edema. Clin Imaging 33:96–101CrossRefPubMed Pavlisa G, Rados M, Pavlisa G, Pavic L, Potocki K, Mayer D (2009) The differences of water diffusion between brain tissue infiltrated by tumor and peritumoral vasogenic edema. Clin Imaging 33:96–101CrossRefPubMed
39.
Zurück zum Zitat Min ZG, Niu C, Rana N, Ji HM, Zhang M (2013) Differentiation of pure vasogenic edema and tumor-infiltrated edema in patients with peritumoral edema by analyzing the relationship of axial and radial diffusivities on 3.0T MRI. Clin Neurol Neurosurg 115:1366–1370CrossRefPubMed Min ZG, Niu C, Rana N, Ji HM, Zhang M (2013) Differentiation of pure vasogenic edema and tumor-infiltrated edema in patients with peritumoral edema by analyzing the relationship of axial and radial diffusivities on 3.0T MRI. Clin Neurol Neurosurg 115:1366–1370CrossRefPubMed
40.
Zurück zum Zitat Zamecnik J (2005) The extracellular space and matrix of gliomas. Acta Neuropathol 110:435–442CrossRefPubMed Zamecnik J (2005) The extracellular space and matrix of gliomas. Acta Neuropathol 110:435–442CrossRefPubMed
41.
Zurück zum Zitat Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: Response assessment in neuro-oncology working group. J Clin Oncol 28:1963–1972CrossRefPubMed Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: Response assessment in neuro-oncology working group. J Clin Oncol 28:1963–1972CrossRefPubMed
Metadaten
Titel
Evaluation of low-grade glioma structural changes after chemotherapy using DTI-based histogram analysis and functional diffusion maps
verfasst von
Antonella Castellano
Marina Donativi
Roberta Rudà
Giorgio De Nunzio
Marco Riva
Antonella Iadanza
Luca Bertero
Matteo Rucco
Lorenzo Bello
Riccardo Soffietti
Andrea Falini
Publikationsdatum
30.08.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 5/2016
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-015-3934-6

Weitere Artikel der Ausgabe 5/2016

European Radiology 5/2016 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.